EMEA-000329-PIP02-09-M05
Key facts
Invented name |
Aranesp
|
Active substance |
darbepoetin alfa
|
Therapeutic area |
Oncology
|
Decision number |
P/0147/2016
|
PIP number |
EMEA-000329-PIP02-09-M05
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
Treatment of anaemia due to chronic disorders
|
Route(s) of administration |
|
Contact for public enquiries |
Amgen Europe B.V
|
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-000329-PIP02-09-M05
|
Compliance opinion date |
24/03/2017
|
Compliance outcome |
negative
|